The U.S. market for large bone and joint orthopedic devices is expected to grow to approximately $2 billion by 2020, according to a new report from iData research.
According to the report:
• Primary hip replacement procedures were the second most predominantly performed hip and knee implant replacement procedure in 2013, behind knee arthroplasty.
• As of 2013, X-linked PE bearings comprised the vast majority of implants used.
• The high profile failure of some metal-on-metal bearings led the U.S. Food and Drug Administration to examine the efficacy and safety of five new implants used in major joint reconstruction surgeries. The research found no convincing evidence supporting the use of the newer devices.
• Vitamin E is starting to become more prevalent in the orthopedics industry, most commonly used in hip, shoulder and knee implants.
More articles on devices:
K2M stock hits crucial point — 5 things to know
Providence Medical Technology gets 3 spine-related patents
Amedica appoints Anan Natarajan vice president of business development